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Abstract
Background: Immunohistochemical methods based on the high affinity of avidin and biotin (e.g.
ABC, LSAB) are characterized by high sensitivity and are widely used for detection of immunologic
reaction. However, a non-specific reaction, observed in frozen tissues and in paraffin-embedded
material, increasing after heat induced epitope retrieval (HIER), and caused either by endogenous
biotin or any another chemical compound with high affinity for avidin, may lead to diagnostic
mistakes. The aim of our investigation is to study presence of endogenous avidin biotin activity
(EABA) in thyrocytes originating from various thyroid pathological lesions (neoplastic and non-
neoplastic).
Materials and methods: The immunohistochemical study was performed on paraffin-embedded
specimens of surgically resected thyroid tissue from 97 patients with thyroid diseases: 65 patients
with papillary carcinoma (PTC), 11 patients with nodular goiter in whom features of benign
papillary hyperplasia were found, 9 with lymphocytic thyroiditis (LT), 8 with follicular adenoma, and
4 patients with follicular carcinoma. In PTC immunohistochemical study was performed both in
primary tumors and in lymph node metastases. After HIER, incubation with streptavidin from
LSAB+ (DakoCytomation) kit was done.
Results: Strong cytoplasmic EABA was observed in 56 of 65 (87.5%) PTC and in oxyphilic cells in
8 of 9 cases of LT. Significant correlation between EABA in primary PTC tumor and EABA in lymph
node metastases was stated. Normal surrounding thyroid tissues showed absence or weak EABA.
Aberrant intranuclear localization of biotin was noted in morules of cribriform-morular variant of
PTC. No statistically significant correlation between patient's age, sex, metastases presence and
EABA was observed.
Conclusion: Among thyroid lesions, false positive reactions are highly probable in papillary thyroid
carcinoma and in lymphocytic thyroiditis if immunohistochemical detection is used on systems
containing (strept)avidin. The most probable reason is the high endogenous biotin content.
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For immunohistochemical diagnostics of thyroid dis-
eases, it is very important to choose an optimal visualiza-
tion method and an appropriate quality control. The
evaluation has to include control for endogenous biotin,
which is widely distributed in tissues and may cause non-
specific staining by binding to avidin.
Biotin is a cofactor required by enzymes that are involved
in carboxylation reactions, e.g. pyruvate carboxylase,
which catalyses the conversion of pyruvate to oxaloacetate
in initiation of gluconeogenesis and acetyl-CoA carboxy-
lase that catalyzes the committed step in fatty acid biosyn-
thesis [1]. The best-known and well understood role of
biotin is to form the prosthetic group of the five biotin-
containing carboxylases. Biotin is covalently bound to a
lysine residue in acetyl-CoA carboxylase 1 (ACC-1), and
acetyl-CoA carboxylase 2 (ACC-2), propionyl-CoA car-
boxylase (PCC), pyruvate carboxylase (PC) and methyl-
crotonyl-CoA carboxylase (MCC). This explains its
obligatory involvement in the metabolism of carbohy-
drates, lipids and deaminated residues of some amino
acids. Moreover, another biotin function as gene expres-
sion regulator was reported recently [2,3].
Immunohistochemical methods based on the high affin-
ity of avidin or streptavidin and biotin are wide known
and used routine methods (e.g. ABC, LSAB) and are char-
acterized by high sensitivity. However, a non-specific reac-
tion can be observed in frozen tissues and in paraffin
embedded material, evoked by high temperature (during
warming in microwave oven or bain-marie), caused by
endogenous biotin or another chemical compound with
high affinity for avidin. Endogenous avidin biotin activity
(EABA) is present in a wide range of epithelial tissues,
especially in glandular epithelia, both normal and tumor-
derived [4]. Some of the thyroid neoplasms exhibit a lot
of endogenous biotin that limits or excludes possibility of
visualization by immunostaining with methods based on
avidin-biotin combined with selected antigen retrieval [4-
8].
In our investigation, we were interested in a more detailed
evaluation of EABA presence in thyrocytes originating
from various thyroid pathological lesions, mainly neo-
plastic, but also non-neoplastic ones. For comparison
with papillary carcinoma (PTC), we choose those cases of
nodular goiter, where signs of papillary hyperplasia were
present. We were looking for association between pres-
ence of EABA in thyrocytes and factors related to the host
(age and sex), factors intrinsic to the tumor (histological
type), and others factors that reflect the relationship
between the host and the tumor (local lymph node metas-
tases).
Materials and methods
The study was conducted on surgically resected thyroid
tissue from 97 patients with thyroid diseases. There were
65 patients with PTC (classical (53), follicular (10) and
oxyphilic (1) cribriform-morular (1) variants), 20 cases of
PTC (15 cases classical variant and 5 cases follicular vari-
ant have lymph node metastases), 11 patients with nodu-
lar goiter and features of benign papillary hyperplasia, 9
with lymphocytic thyroiditis, 8 with follicular adenoma, 4
patients with follicular carcinoma (FTC) (Table 1). Age
range was 8 – 78 and mean age 44 years. There were 81
women and 16 men among the studied patients.
Paraffin-embedded specimens were used in the immuno-
histochemical study. Sections were cut for 5 μm and
mounted on Poly-L-lysine coated slides. After deparafini-
sation, antigen retrieval was carried out in citrate buffer
pH = 6.0 by microwave treatment (3 cycles for 5 minutes,
750 W). After cooling, the sections were immersed in 3%
hydrogen peroxide to block endogenous peroxidase activ-
ity – 5 minutes, then washed in TBS buffer pH = 7,6 for 5
minutes. Incubation with streptavidin from LSAB+/HRP
kit (DakoCytomation) lasted 25 min, then the slides were
washed in TBS buffer 2 times for 5 minutes and incubated
with DAB for 10 min, washed in distilled water and
stained with hematoxylin for 1 minute. For control pur-
poses, all cases were also evaluated by EnVision visualiza-
tion system (DakoCytomation). Micrographs were done
with Carl Zeiss Axioplan 2 microscope, Sony 3CCD color
video camera using KS400 (Carl Zeiss) software.
Results
Both cytoplasmic and nuclear reaction with endogenous
biotin was observed in thyroid tissue. The EABA-positive
results were obtained in thyroid glands of 72 patients,
among them 57 of 65 PTC cases, 1 of 11 nodular goiter
cases showing signs of benign papillary hyperplasia, 8 of
9 lymphocytic thyroiditis cases, 1 of 4 FTC cases. The most
intensive EABA was observed in cases of PTC and lym-
phocytic thyroiditis (Table 2). Essentially to note, no
immunostaining was observed using EnVision visualiza-
tion system that does not contain avidin or streptavidin.
Consequently, nonspecific staining resulting from EABA
was eliminated (Figure 1).
The majority of PTC (87.7%) showed intensive EABA. The
reaction was weaker in follicular variant of PTC. Positive
cytoplasmic EABA in histologically normal surrounding
tumor thyroid tissue was observed in 61.8% of PTC cases.
In all cases of positive surrounding tissue reaction, it was
weak with fewer positive cells than observed in tumor tis-
sue. No statistically significant correlation was found
between EABA and patients' sex, age, or, in the case of can-
cer cases, the lymph node metastases presence. A positive
correlation between EABA intensity in primary tumor andPage 2 of 7
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(Spearman R = 0.83 p-level = 0.008).
In addition, we observed aberrant intranuclear localiza-
tion of biotin in morules of cribriform-morular variant of
PTC. This rare variant of PTC was seen only in one patient,
22 years old female. The reaction was observed during
immunostaining for Cytokeratin 7 (CK-7). In glandular
component of the tumor there was positive membranous
reaction for CK-7 and negative for nuclear biotin. Morular
component of the tumor was immunonegative for CK-7
but positive for biotin in nucleus (Figure 2).
Cytoplasmic EABA was observed just in one case of nodu-
lar goiter and the reaction was present in oxyphilic cells.
In lymphocytic thyroiditis, intensive and widespread cyto-
plasmic EABA was observed in thyrocytes with oxyphilic
metaplasia that were located around lymphoid germinal
centers (Figure 3). In follicular adenoma weak EABA was
noted just in few cells. To evaluate a possible diagnostic
significance of EABA in distinguishing PTC from other
Table 1: Patient's diagnosis, sex, middle age and presence of nodular metastases
Diagnosis Patients sex
M F Patients Age (mean, SD) Lymph Node metastases
PTC (all) 14 51
PTC (classical variant) 10 43 46 ± 17.22 19
PTC (follicular variant) 4 6 32 ± 18.52 4
PTC (oxyphilic variant) 0 1 42 0
PTC (cribrifirm-morular variant) 0 1 22 0
Nodular goiter with benign nodular hyperplasia 1 10 44 ± 13.71 -
Lymphocytic thyroiditis 0 9 50 ± 13.07 -
Follicular adenoma 1 7 46 ± 12.84 -
FTC 0 4 48 ± 14.49 0
Cytoplasmic EABA in PTC tissueFigure 1
Cytoplasmic EABA in PTC tissue. a) Cytoplasmic EABA in papillary thyroid carcinoma cells (LSAB+); objective magnifica-
tion 5×; b) No reaction in the same sample of PTC (EnVision); objective magnification 5×.
a) b)
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under the curve (AUC) was 0.721.
Discussion
Endogenous biotin activity has been indicated by previ-
ous studies dealing with thyroid immunohistochemistry
(Table 3). Our study extends these data and indicates that
EABA activity is present in thyroid lesions which are abun-
dant in mitochondria (oxyphilic metaplasia, oxyphilic
tumors) and in papillary thyroid cancer, both primary
tumor and lymph node lesions, but not in benign goiter
showing features of papillary hyperplasia. Bussolati et al.
(1997) in their study proposed even constitutive endog-
enous biotin as a putative diagnostic marker [9]. Our
study negates this possibility, as the area under ROC curve
does not reach 80%.
Endogenous biotin immunoreactivity was generally not
visualized in formalin-fixed, paraffin-embedded tissues
Table 2: EABA intensity in different thyroid lesions
Thyroid disease Number of positive cases EABA Intensity
PTC (all) 57/65 +++
PTC (classical variant) 47/53 +++
PTC (follicular variant) 8/10 ++
PTC (oxyphilic variant) 1/1 +++
PTC (cribrifirm-morular variant) 1/1 +++
(nuclear)
Nodular goiter with benign nodular hyperplasia 1/9 ++
Lymphocytic thyroiditis 8/9 +++
Follicular adenoma 4/7 +
Follicular carcinoma 1/4 ++
Note: + brown staining in less then 20% of cells; ++ brown staining between 20% – 60% of cells; +++ brown staining more than 60% of cells.
Aberrant biotin in nuclei of morular cells of PTC cribrifirm-morul r variantFigu e 2
Aberrant biotin in nuclei of morular cells of PTC cri-
brifirm-morular variant. CK-7 stain (LSAB+ visualization 
method) glandular cells show CK-7 expression (membranous 




Cytoplasmic EABA in follicular cells in lymphocytic thyroiditisFigure 3
Cytoplasmic EABA in follicular cells in lymphocytic 
thyroiditis. (LSAB+); objective magnification 5×.Page 4 of 7
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been introduced. The thermal denaturation of tissue sec-
tions by microwave pre-treatment or pressure-cooking
techniques is used to unmask tissue epitopes exposing
endogenous biotin and thus can result in spurious immu-
nohistochemical staining [10,11].
Endogenous biotin levels in human cells are especially
high in liver, renal tubular epithelium, brown fat and
adrenal cortex. Bussolati et al. (1997) was the first who
showed that numerous other human tissue types might
demonstrate endogenous biotin expression following
antigen retrieval processes (autoclaving or microwaving)
and listed also PTC (3 of 5 studied) and oncocytic type of
follicular thyroid carcinoma (OTC) (5 of 5 studied)
among analyzed human neoplasms in this study [9]. In
study of Zhou X et al. (2002) EABA in PTC and OTC was
easier revealed by higher pH value buffer (EGTA pH 9.0)
than that with lower pH value (EDTA pH 8.0 and citrate
pH 6.0). Kashima K et al. [6] demonstrated that cytoplas-
mic biotin-like activity could be identified in formalin-
fixed and paraffin-embedded human thyroid lesions by
immunostaining for biotin using peroxidase-antiperoxi-
dase method or by peroxidase-labeled streptavidin alone.
The reactivity of cytoplasmic biotin-like activity was mark-
edly enhanced both by pretreatment with trypsin and
after heating by autoclaving. The positive incidence of
cases and positive cell ratio were the highest in papillary
carcinoma, followed by follicular carcinoma and the low-
est in anaplastic carcinoma, squamous cell carcinoma and
poorly differentiated insular carcinoma.
Also, thyroid oxyphilic cells are known to have high
endogenous biotin and are known to show a false-posi-
tive immunohistochemical staining [12]. Oxyphilic cells
were identified with biotin detection system when the pri-
mary antibody was omitted after microwaving in Tris
buffer pH = 7.4 [13].
Among carboxylases requiring biotin as their coenzyme,
PC, PCC, MCC and ACC-2 are located in mitochondria,
ACC-1 is the only one known biotin-dependent carboxy-
lase located in human cell cytoplasm. For this reason,
much of the false positivity caused by endogenous biotin
in immunohistochemical studies is a cytoplasmic immu-
noreaction which is found in tissues with abundant mito-
chondria [10], when avidin and streptavidin, closely
related tetrameric proteins, which share a strong affinity
for biotin, are used. This extremely strong non-covalent
interaction is the basis for multitude of non-radioactive
techniques used in the detection of macromolecules.
Human organism is unable to synthesize biotin and thus
depends entirely on the vitamin presence in food to satisfy
its vitamin requirements. To deal with their biotin
requirements, humans have evolved to a very efficient and
complex biotin cycle to ensure adequate supply and utili-
zation of the vitamin. There are two enzymes involved in
Table 3: EABA in thyroid tissue according to published studies
Antigen retrieval method Type of thyroid lesion Observation
Bussolati et al. (1997) [9] Autoclaving; microwave OTC Expression ++ in 5/5
PTC Expression + in 3/5
Kashima K et al. (1997) [6] Trypsin pretreatment; Autoclaving Various thyroid lesions Expression + in 93/208
PTC and FTC Higher expression
ATC, squamous cell carcinoma; 
poorly differentiated carcinoma
Lowest expression
Zhou X et al. (2002) [4] Microwaving in EGTA buffer pH 
9.0; 8.0; 6.0
C cells, PTC, OTC EABA was easier revealed by higher 
pH value buffer (EGTA pH 9.0) than 
that with lower pH value 
(EDTA pH 8.0 and citrate pH 6.0)
Herrmann ME et al. (2002) [13] Microwaving in 0.1 Tris buffer pH 
7.4
PTC, reactive oxyphilic cells identified with biotin detection system 
when the primary antibody was 
omitted
Mutsomoto F et al. (2006) [12] Microwaving in citric acid (pH 6.0) 
for 10 minutes at 100°C
oxyphilic cells Elimination of nonspecific staining due 
to endogenous avidin-biotin activity by 
using En-Vision+ system HRP-labeled 
polymerPage 5 of 7
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which covalently attaches biotin to carboxylases and
biotinidase (BTD), the enzyme responsible for biotin
recycling. BTD catalyzes the hydrolysis of biocytin, a nor-
mal product of biotin-dependent carboxylase degrada-
tion, to biotin and lysine, thus allowing biotin to be
recycled and used in biotinylation of new carboxylases
[14]. The biotin-binding/carrier function of BTD has been
demonstrated. It can be responsible for transporting
biotin into cells through a specific cell membrane receptor
[15,16]. In addition, biotin-transferase activity of BTD in
modification of genes expression by biotinylation of his-
tones was shown [17-20]. Biotinidase activity is particu-
larly high in liver, adrenal gland and kidney [15].
Previous studies demonstrated that cytoplasmic EABA was
caused by biotin-containing carboxylases. Praul et.al
(1998), using Western-blot, detected three biotin-con-
taining carboxylases (PC, MCC and PCC) utilizing
streptavidin alone [21] and concluded that EABA was
higher in tissues with high rate of metabolism. On the
other hand, the cause and mechanism of biotin storing is
still not exactly clear [15,16,22].
Although the main biotin rich fractions are the cytosol
and the mitochondria, there is some controversy as to
whether moderate or negligible amounts of biotin are
present in the nuclei of cells as well. Biotin was discussed
to be present in optically clear nuclei of ovarian endome-
trioid carcinoma, pancreatoblastoma, pulmonary blast-
oma, pulmonary endodermal tumor and morules within
colonic tubular adenoma and thyroid carcinoma [10]. It
was suggested that the observed phenomena were caused
by biotinylation of histones or might be indirect through
the involvement of biotin in the synthesis of ATP and pro-
tein enzymes [10,15,16]. In our study, we also observed
nuclear EABA in cribriform-morular variant of PTC nuclei.
Majority of authors consider EABA in thyroid tissue to be
an artifact that limits or even excludes using avidin/
streptavidin-containing detection systems for immuno-
chemistry. It is important to note that immunohisto-
chemical profile of PTC cells is very similar to that
exhibited by the follicular cells in lymphocytic thyroiditis,
a fact that should be taken into account in the differential
diagnosis between the two entities and before the making
a claim about the "specificity" of a given antibody to PTC
[23].
In addition to the diagnostic and biological aspects, the
present study is obviously of methodological interest in a
wider sense. Although not every application of the
(strept)avidin/biotin technology is necessarily affected by
endogenous biotin, the problem certainly extends beyond
immunohistochemistry (e.g. the recent proposals to intro-
duce in vivo therapies based on application of biotin).
Therefore, precautions should be taken by determining
whether endogenous biotin interferes with avidin-biotin
applications.
Conclusion
Endogenous avidin biotin activity presence in papillary
thyroid carcinoma cells and oxyphilic cells can cause cyto-
plasmic and nuclear false-positive immunohistochemical
staining. Thus, using of visualization systems that do not
contain (strept)avidin is necessary for immunohisto-
chemistry of thyroid disease. If it is necessary to use
streptavidin-containing detective systems, the examina-
tion of tissue-specific negative controls with every immu-
nohistochemical study is necessary. However, we do not
support use of EABA for distinguishing PTC from other
thyroid lesions because of its frequent presence in thyroid
oxyphilic cells.
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